14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
JULJ vs APRJ: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Innovator Premium Income 30 Barrier ETF - April (APRJ) is the stronger overall head-to-head candidate over Innovator Premium Income 30 Barrier ETF - July (JULJ) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). JULJ carries a Unified Composite Score of 55.7/100 (HOLD) at $24.82 (N/M Forward P/E, N/A operating margin), whereas APRJ carries 52.8/100 (HOLD) at $24.69 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While JULJ currently prints a higher short-term Unified Composite Score (55.7/100 HOLD vs. APRJ 52.8/100 HOLD), APRJ captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Technical & Structure Timing Caution: JULJ is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.8); meanwhile APRJ is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on JULJ vs APRJ. Trailing 12-month operating profitability (JULJ N/A vs APRJ N/A) and valuation multiples (JULJ N/M vs APRJ N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ JULJ vs APRJ Key Questions & Quantitative Answers
As of Nov 16, 2026, Innovator Premium Income 30 Barrier ETF - April (APRJ) is the stronger overall head-to-head candidate over Innovator Premium Income 30 Barrier ETF - July (JULJ) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). JULJ carries a Unified Composite Score of 55.7/100 (HOLD) at $24.82 (N/M Forward P/E, N/A operating margin), whereas APRJ carries 52.8/100 (HOLD) at $24.69 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While JULJ currently prints a higher short-term Unified Composite Score (55.7/100 HOLD vs. APRJ 52.8/100 HOLD), APRJ captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: JULJ is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.8); meanwhile APRJ is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 46.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
JULJ and APRJ split Growth & Scale metrics: JULJ posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with APRJ at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, JULJ generates N/A in USD-normalized revenue versus N/A for APRJ. In operating R&D and SG&A reinvestment, JULJ deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for APRJ.
JULJ and APRJ trade at balanced relative valuation multiples. JULJ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas APRJ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against JULJ (N/A ROE) versus APRJ (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, JULJ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.08β · 5% Vol realized risk). By comparison, APRJ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.03β · 2% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.